Enzolytics Inc (ENZC)

[all the way up green]

Taken from my E*TRANDE account


Company Overview
Sector
Healthcare
Industry
Biotechnology & Medical Research
RobustoMed, Inc., formerly Enzolytics Inc., is a drug development company. The Company is focused on commercialization of its proteins for the treatment of human immunodeficiency viruses (HIV)/ acquired immunodeficiency syndrome (AIDS). It is also focused on exploring/developing additional applications of its immunotherapy compounds. The Company's flagship compound, Immune Therapeutic Vaccine-1 (ITV-1) is a suspension of Inactivated Pepsin Fraction (IPF). IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system.
Headquarters
120 W Pomona Ave
Monrovia, CA
91016-4557
enzolytics.com